Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Plos One|April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumorsSeyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Diagnostics (Basel, Switzerland)|October 16, 2024
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 TumorsFlorian Lutz, Soo-Young Han, Seyma Büyücek, et al.
Archives of Pathology & Laboratory Medicine|March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical TissueMaximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
Cancers|July 13, 2024
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor EntitiesAnne Menz, Julia Zerneke, Florian Viehweger, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumorsViktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Biomarker Research|December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samplesSeyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology|January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entitiesFlorian Viehweger, Carola Böcker, Sören Weidemann, et al.
Pageof 5